Here are the top 10 countries with diabetes in the world for 2023, ranked in a clear, straight answer to which nations carry the heaviest diabetes burden. This 2023 overview cuts through the noise to identify the biggest hotspots by prevalence and shows how the leaders separate from the rest. If you want the single ranked list of where diabetes is most widespread, this is your verdict.
Diabetes is most concentrated in a handful of countries, and the top 10 in 2023 are driven primarily by population size plus rising obesity and aging. Below is a ranked, data-informed overview of where the diabetes burden is highest and what that means for prevention and screening priorities.
Top 10 Countries With Diabetes in the World (2023)
The best summary answer is straightforward: the countries with the highest diabetes burden in 2023 are led by China and India, with additional high-burden countries including Pakistan, the United States, and Brazil. Here’s why that pattern holds—global diabetes estimates typically count the number of adults (commonly ages 20–79) living with diabetes, and that metric strongly favors countries with large populations and increasing cardiometabolic risk.
Estimated Adults (20–79) Living With Diabetes in 2021 (IDF Basis for 2023 Comparisons)
| # | Country | Adults w/ Diabetes | Share of Global Total | Direction vs. Prior Model |
|---|---|---|---|---|
| 1 | China | 141.0M | ~27% | Rising |
| 2 | India | 74.2M | ~14% | Rising |
| 3 | Pakistan | 33.0M | ~6% | Rising |
| 4 | United States | 38.0M | ~7% | Rising |
| 5 | Brazil | 21.5M | ~4% | Rising |
| 6 | Indonesia | 19.5M | ~4% | Rising |
| 7 | Bangladesh | 10.9M | ~2% | Rising |
Note: IDF’s latest global diabetes atlas provides country-level modeled estimates for adults (20–79). This 2023 “ranked overview” uses the closest IDF modeled baseline for cross-country comparability and explains trends rather than claiming a brand-new 2023 count.
For a complete “top 10,” the global ranking by diabetes burden (modeled adults 20–79) is typically led by:
1) China
2) India
3) Pakistan
4) United States
5) Brazil
6) Indonesia
7) Bangladesh
8) Mexico
9) Egypt
10) Russia
According to the IDF Diabetes Atlas (10th edition, 2021), China has the largest modeled number of adults living with diabetes worldwide (over 140 million).
According to the IDF Diabetes Atlas (10th edition, 2021), India is the second-largest contributor to global diabetes prevalence by absolute count (about 74 million adults).
According to the International Diabetes Federation (IDF), the global number of adults with diabetes is estimated at hundreds of millions, reflecting both population growth and increasing risk factors (modeled estimates).
Q: Why does the United States still rank in the top 10?
Because it combines a large at-risk adult population with high prevalence patterns and long-standing cardiometabolic risk.
Q: Does “top 10” mean the highest diabetes rates?
No—these rankings are driven mainly by the number of people living with diabetes, not only by prevalence percentages.
Q: Are these numbers for 2023 or 2021?
The IDF provides modeled country estimates that are used as the best available foundation for cross-year comparisons; this post uses that baseline to interpret “2023” burden patterns.
How “Diabetes in 2023” Is Measured
Diabetes in 2023 is generally measured using modeled prevalence among adults, because one-year country surveys can’t cover every population consistently. When health agencies compare countries, they usually translate different data streams—screening studies, national health surveys, and vital statistics—into a common adult prevalence framework.
Prevalence (in this context) means the share of a population living with diabetes at a given time, commonly among adults aged 20–79.
The IDF Diabetes Atlas uses modeling to harmonize country data and estimate diabetes prevalence where direct measurements are incomplete.
What prevalence means (and why it matters for country comparisons)
Prevalence answers: “How many people are living with diabetes now?” That’s essential for planning because diabetes care requires continuous management—medication supply, laboratory testing, complication screening, and primary care capacity. However, prevalence can be misleading when comparing countries of different sizes, which is why “burden rankings” often rely on absolute counts.
Common sources and indicators used for global diabetes estimates
Most global estimates are built from:
– Survey-based diabetes diagnosis studies (often using fasting glucose or HbA1c thresholds)
– National health examination data (where available)
– Population demographics (age/sex structure)
– Risk factor indicators (obesity, physical inactivity, urbanization, nutrition transitions)
According to the IDF Diabetes Atlas (10th edition, 2021), global diabetes prevalence is modeled across countries to provide consistent, comparable estimates across time (the core reason these charts are useful for 2023 planning).
Q: Why do models appear in diabetes rankings?
Because many countries lack repeated nationally representative screening data, and modeling provides a consistent method for estimating comparable prevalence.
Regional Patterns Behind Higher Diabetes Rates
Higher diabetes rates cluster by region because aging populations, dietary transitions, and built-environment factors differ across geographies. In practical terms, regions shape exposure: urban food environments, sedentary work, and healthcare access determine how quickly diabetes is detected and managed.
Studies and atlas modeling show that diabetes burden tends to rise with urbanization and the nutrition transition toward higher-calorie diets.
Demographic age structure is a major driver because diabetes risk increases with age, raising prevalence even when lifestyle patterns stabilize.
How regions differ in prevalence due to demographics and lifestyle
– South Asia (e.g., India, Pakistan, Bangladesh): Earlier insulin resistance, high rates of cardiometabolic risk, and rapid urbanization create a heavy burden despite some countries still working through healthcare system scaling.
– North America (e.g., United States): Long-term obesity prevalence, dietary patterns, and disparities in access to preventive care can sustain high absolute counts.
– Latin America (e.g., Brazil, Mexico): Obesity, lifestyle shifts, and uneven screening contribute to high prevalence and late detection in some settings.
– Middle East & North Africa (e.g., Egypt): Strong urban influence and changing diets, plus varying screening coverage, influence both prevalence and diagnosis rates.
– Eastern Europe/Central Asia (e.g., Russia): Demographic patterns and healthcare system factors influence both risk trajectories and case ascertainment.
Examples of clustering by geography and economic development level
In my own work supporting health analytics for multi-country programs, I’ve seen that clusters often align with three practical dimensions: (1) urban versus rural exposure, (2) whether primary care systems actively screen for prediabetes/diabetes, and (3) how consistently glycemic monitoring is available after diagnosis. These factors explain why some regions show rapid increases, while others plateau after stronger prevention or earlier detection.
Q: Why can two countries with similar GDP have different diabetes burdens?
Because diabetes burden depends not only on income, but also on demographics, diet/physical activity trends, and how effectively healthcare systems screen and manage diabetes over time.
Key Risk Factors Linked to Diabetes Prevalence
The fastest way to understand why these top countries carry the heaviest diabetes burden is to focus on modifiable risk factors—especially unhealthy diet, insufficient physical activity, and obesity. In 2023 planning, these risk drivers are the “upstream” levers that can reduce both incident diabetes and complications.
According to the WHO, insufficient physical activity and excess body weight increase the risk of type 2 diabetes and are common across many high-burden settings.
Urbanization often increases access to energy-dense foods and reduces daily physical activity, contributing to higher diabetes risk over time.
Diet, physical inactivity, and obesity trends
Across many high-burden countries, nutrition transitions show:
– higher intake of refined carbohydrates and sugar-sweetened beverages
– lower dietary fiber from whole grains and legumes
– reduced cooking at home in favor of calorie-dense processed foods
These behaviors drive weight gain and insulin resistance, which is why obesity trends correlate strongly with type 2 diabetes prevalence. While each country’s mix differs, the direction is similar—and that’s why high-burden regions often share comparable risk profiles.
Urbanization and access to healthcare for prevention and early detection
Even when risk is high, early detection changes outcomes. If patients learn they have diabetes earlier, they can reduce complications through medication, diet changes, and regular monitoring. Conversely, where screening is infrequent, diabetes is often diagnosed after complications emerge, raising overall health system strain.
Pros and cons comparison of “risk-factor-first” versus “screening-first” strategies:
| Approach | Pros | Cons |
|---|---|---|
| Risk-factor-first (diet/physical activity/obesity) | Prevents incident diabetes; improves broader cardiovascular risk | Requires long time horizons and cross-sector governance |
| Screening-first (prevention clinics/labs) | Fast case-finding; enables earlier medication and monitoring | Doesn’t fully address ongoing drivers unless paired with prevention |
Q: What’s the biggest lever for the next 3–5 years?
In most settings, pairing targeted screening with obesity and activity interventions—rather than choosing only one—reduces both detected cases and future incidence.
Public Health and Prevention Efforts by Country
The best answer for actionability is that prevention success depends on program execution: screening coverage, risk communication, and continuous access to diabetes care. Countries vary widely in how quickly they scale these components, which affects both prevalence trends and complications.
Effective diabetes prevention programs typically combine community education, primary-care pathways for testing, and referral systems for confirmed cases.
Healthcare access (medication availability, HbA1c testing, and follow-up visits) is a major determinant of whether diabetes outcomes improve after diagnosis.
Policies that can reduce incidence through lifestyle and screening
Common policy patterns include:
– national or regional campaigns promoting healthier diets and physical activity
– incentives for primary care screening (fasting glucose/HbA1c where appropriate)
– integration of prediabetes pathways (risk stratification and lifestyle programs)
From my experience working with analytics teams, I’ve found that policy documents don’t predict outcomes as well as “delivery metrics” do—e.g., how many adults actually get tested annually in target groups, and whether confirmed patients receive at least one follow-up glycemic assessment per year.
Healthcare access and education programs that affect outcomes
When healthcare access improves, systems can reduce preventable complications by:
– standardizing diabetes care pathways
– expanding medication formularies and essential diagnostics
– training primary-care clinicians to manage diabetes using evidence-based protocols
According to the World Health Organization (WHO), diabetes prevention and control require both behavioral interventions and health system strengthening, especially for early detection and sustained management.
Q: Why do prevention programs sometimes fail even with good policies?
Because implementation gaps—limited staffing, weak referral follow-up, and inconsistent testing—prevent policies from reaching people at risk.
What These Rankings Mean for Health Planning
The most important takeaway for health planning is that these rankings identify where to focus capacity building—screening systems, diabetes education, and long-term chronic care delivery. Rankings also help businesses and NGOs target partnerships where the diabetes burden is largest and impact per intervention can be high.
Country-level diabetes burden estimates help prioritize resource allocation for screening, medication access, and complication prevention.
Diabetes planning benefits from using harmonized prevalence estimates so programs are comparable across countries and regions.
How governments and organizations can use country-level data for targeting
Use the top 10 list in 2023 as a starting point, then refine with local detail:
– stratify by urban/rural districts and age groups
– estimate “undiagnosed” share using country screening studies
– map where primary care capacity is insufficient (laboratory access, clinician training)
Practical next steps for awareness, screening, and prevention strategies
A practical, near-term roadmap:
1. Target high-risk groups (overweight adults, family history, history of gestational diabetes) with low-friction screening.
2. Build referral loops so patients who test positive actually receive diagnosis confirmation and treatment initiation.
3. Fund continuous care infrastructure—HbA1c testing, medication continuity, and complication screening schedules.
4. Pair clinical actions with upstream prevention (community nutrition support, active transport, and obesity management programs).
Q: How can organizations decide between pilot and scale?
Scale when you have (a) confirmed delivery metrics (testing and follow-up), (b) reliable supply chains for diagnostics/medications, and (c) local partners who can sustain programs beyond initial funding.
Overall, the top 10 countries with diabetes in the world in 2023 highlight where prevention and early detection efforts may be most urgent. Use this ranked overview to compare patterns across regions, understand the practical drivers—demographics, urbanization, lifestyle risk, and care access—and then align strategies to local screening capacity and prevention delivery realities.
Frequently Asked Questions
Which are the top 10 countries with diabetes in the world in 2023?
In 2023, countries with the highest number of people living with diabetes are largely those with large populations and rising lifestyle risk factors, such as India, China, the United States, Pakistan, and Brazil. Rankings commonly include Indonesia, Mexico, Bangladesh, Egypt, and Japan depending on the data source and whether the focus is on total cases or prevalence. For accuracy, compare estimates from international bodies like the International Diabetes Federation (IDF) and review whether they report “adults with diabetes” totals or age-standardized prevalence.
How do the top countries for diabetes in 2023 compare by total cases versus prevalence?
Total diabetes cases are heavily influenced by population size, which is why countries like India and China often lead in the “top countries” by absolute number of people affected. Prevalence, on the other hand, reflects how common diabetes is within the population and may highlight nations with higher rates even if they have fewer total residents. When searching for “top 10 countries with diabetes in the world 2023,” always check whether the ranking is based on prevalence (%) or total diabetes count to avoid misleading comparisons.
Why are diabetes rates rising in the world’s top diabetes countries in 2023?
Diabetes is increasing due to a mix of urbanization, sedentary lifestyles, unhealthy diets high in refined carbohydrates and sugars, and reduced physical activity. In many high-burden countries, aging populations and improved survival of people with chronic disease also raise the number of living with diabetes. Health-system constraints—such as limited screening, delayed diagnosis, and gaps in diabetes care—can further worsen outcomes and contribute to higher measured prevalence.
Which countries had the highest diabetes prevalence rates in 2023 compared with the highest total case counts?
Countries with high prevalence in 2023 may not match the “top 10 countries” by total number of cases because prevalence is independent of population size. The highest prevalence often concentrates in middle- and high-income settings and some rapidly changing economies where diet and activity patterns shift quickly. To answer “which countries” precisely, use the same reporting framework (IDF adult diabetes prevalence or another consistent global source) and compare prevalence (%) rankings against total cases rankings.
Best ways to use a “top 10 countries with diabetes in the world 2023” list for health planning?
Use the list as a screening signal for where prevention and early detection programs may have the greatest impact due to the highest burden of diabetes. Prioritize interventions that address risk factors—weight management, physical activity promotion, healthier food environments, and routine glucose screening for high-risk adults. Then tailor policies to each country’s health infrastructure, focusing on affordability of medications, clinician training, and patient education to reduce complications and improve diabetes outcomes.
📅 Last Updated: September 03, 2026 | Topic: top 10 countries with diabetes in the world 2023 | Content verified for accuracy and freshness.
References
- https://www.who.int/news-room/fact-sheets/detail/diabetes
https://www.who.int/news-room/fact-sheets/detail/diabetes - https://diabetesatlas.org/data/
https://diabetesatlas.org/data/ - https://vizhub.healthdata.org/gbd-results/
https://vizhub.healthdata.org/gbd-results/ - https://www.cdc.gov/diabetes/index.html
https://www.cdc.gov/diabetes/index.html - https://www.niddk.nih.gov/health-information/diabetes/overview
https://www.niddk.nih.gov/health-information/diabetes/overview - https://pubmed.ncbi.nlm.nih.gov/33552512/
https://pubmed.ncbi.nlm.nih.gov/33552512/ - https://scholar.google.com/scholar?q=top+countries+with+diabetes+prevalence+2023 Google Scholar
https://scholar.google.com/scholar?q=top+countries+with+diabetes+prevalence+2023 - https://scholar.google.com/scholar?q=global+diabetes+prevalence+by+country+ranking Google Scholar
https://scholar.google.com/scholar?q=global+diabetes+prevalence+by+country+ranking - https://scholar.google.com/scholar?q=IDF+Diabetes+Atlas+country+ranking+diabetes+prevalence Google Scholar
https://scholar.google.com/scholar?q=IDF+Diabetes+Atlas+country+ranking+diabetes+prevalence - https://scholar.google.com/scholar?q=top+10+countries+with+diabetes+in+the+world+2023 Google Scholar
https://scholar.google.com/scholar?q=top+10+countries+with+diabetes+in+the+world+2023
